Doximity (NYSE:DOCS) Shares Up 8% – Time to Buy?

Doximity, Inc. (NYSE:DOCS) was up 8% during mid-day trading on Tuesday. The stock traded as high as $34.01 and last traded at $33.9640. 1,256,274 shares were traded during mid-day trading, a decline of 68% from the average session volume of 3,965,258 shares. The stock had previously closed at $31.45.

Trending Headlines about Doximity

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity partnered with Wolters Kluwer Health to make evidence-based content from UpToDate available through Doximity Ask, its AI clinical decision-support tool. The integration is expected to provide clinicians at participating health systems with answers based on approximately 13,000 UpToDate topics and best-practice guides. The deal could improve Ask’s clinical usefulness, support adoption among health systems and strengthen Doximity’s position in healthcare AI, although financial terms were not disclosed. Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask
• Neutral Sentiment: Multiple law firms reiterated that investors in Doximity shares purchased between August 8, 2024, and May 13, 2026, may seek appointment as lead plaintiff by November 16, 2026. These announcements largely repeat existing litigation information rather than introducing a new operational development, but they keep the lawsuit in focus for investors. Rosen Doximity investor deadline notice
• Negative Sentiment: The securities lawsuit alleges that Doximity overstated the contribution of its Newsfeed advertising product to revenue growth, relied on “light engagement” ad formats it had publicly disavowed and misstated its competitive position. The complaint claims investors suffered losses following several sharp share-price declines. The allegations have not been established in court, but potential litigation costs, regulatory scrutiny and questions about advertising-growth quality represent an overhang for DOCS. Doximity securities class action investor alert

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on DOCS shares. Canaccord Genuity Group set a $36.00 price target on shares of Doximity in a report on Friday, August 7th. Weiss Ratings raised shares of Doximity from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, October 6th. Needham & Company LLC restated a “buy” rating and issued a $41.00 price objective on shares of Doximity in a report on Friday, August 7th. Evercore set a $35.00 target price on Doximity in a research report on Tuesday, September 29th. Finally, Truist Financial raised their target price on Doximity from $19.00 to $24.00 and gave the stock a “hold” rating in a research report on Thursday, August 13th. Eight equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $30.73.

Doximity Trading Up 7.3%

The company has a market cap of $6.01 billion, a P/E ratio of 39.69, a PEG ratio of 24.22 and a beta of 1.22. The stock’s 50-day moving average price is $26.87 and its 200-day moving average price is $23.69.

Doximity (NYSE:DOCS) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.13. The firm had revenue of $156.62 million for the quarter. Doximity had a net margin of 25.48% and a return on equity of 18.06%. The firm’s quarterly revenue was up 7.3% on a year-over-year basis. During the same period last year, the business posted $0.36 earnings per share. On average, research analysts anticipate that Doximity, Inc. will post 0.74 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Phoebe Yang sold 1,290 shares of the stock in a transaction dated Wednesday, September 30th. The shares were sold at an average price of $26.71, for a total transaction of $34,455.90. Following the completion of the transaction, the director owned 24,744 shares in the company, valued at approximately $660,912.24. This represents a 4.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Kira Wampler sold 2,000 shares of Doximity stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $28.91, for a total transaction of $57,820.00. Following the completion of the sale, the director directly owned 27,923 shares in the company, valued at $807,253.93. This trade represents a 6.68% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 19,250 shares of company stock worth $613,855 in the last ninety days. Company insiders own 31.80% of the company’s stock.

Institutional Investors Weigh In On Doximity

A number of institutional investors and hedge funds have recently made changes to their positions in DOCS. Versant Capital Management Inc raised its holdings in shares of Doximity by 1,176.9% in the 3rd quarter. Versant Capital Management Inc now owns 1,826 shares of the company’s stock valued at $52,000 after acquiring an additional 1,683 shares in the last quarter. Fortitude Family Office LLC lifted its holdings in shares of Doximity by 31,271.4% in the 3rd quarter. Fortitude Family Office LLC now owns 2,196 shares of the company’s stock worth $62,000 after acquiring an additional 2,189 shares during the last quarter. Parallel Advisors LLC grew its holdings in shares of Doximity by 111.0% during the 1st quarter. Parallel Advisors LLC now owns 2,560 shares of the company’s stock valued at $60,000 after purchasing an additional 1,347 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of Doximity by 937.7% during the 1st quarter. EverSource Wealth Advisors LLC now owns 2,833 shares of the company’s stock valued at $66,000 after purchasing an additional 2,560 shares during the last quarter. Finally, Leonteq Securities AG grew its holdings in shares of Doximity by 65.6% during the 1st quarter. Leonteq Securities AG now owns 2,912 shares of the company’s stock valued at $68,000 after purchasing an additional 1,154 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

About Doximity

Doximity, Inc operates a digital platform designed for medical professionals in the United States. Its network connects physicians, nurse practitioners, physician assistants, pharmacists and other healthcare professionals, providing tools for professional communication, collaboration and career development.

The company offers services including secure messaging, telehealth, digital faxing, physician scheduling and professional networking. Doximity also provides medical news and educational content, as well as recruiting and job-search resources for healthcare professionals.

Doximity generates additional revenue through digital marketing and engagement solutions for pharmaceutical companies, healthcare organizations and health systems.